OHNO YOSHIYA 大野喜也

… Alternative Names

Ohno Yoshiya 大野喜也

OONO Yoshiya 大野喜也

Less

Researcher Number	40509155
Other IDs
Affiliation (Current)	2025: 兵庫医科大学, 薬学部, 准教授
Affiliation (based on the past Project Information) *help	2023 – 2024: 兵庫医科大学, 薬学部, 准教授 2022: 兵庫医科大学, 薬学部, 講師 2018 – 2021: 兵庫医療大学, 薬学部, 講師 2017: 兵庫医療大学, 薬学部, 助教 2009 – 2015: 兵庫医療大学, 薬学部, 助教 2008: 兵庫医療大学, 薬学部, 助手
Review Section/Research Field	Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Tumor biology Except Principal Investigator Basic Section 50020:Tumor diagnostics and therapeutics-related / Immunology / Tumor therapeutics / General pharmacology / Biological Sciences
Keywords	Principal Investigator IL-18 / 免疫チェックポイント阻害薬 / 免疫関連有害事象 / 自然リンパ球 / 免疫関連有害事象 (irAE) / 免疫チェックポイント / 肝傷害 / 上皮間葉転換 / 接着分子 / ヒアルロン酸 / 癌 … More Except Principal Investigator … More 免疫チェックポイント / 癌免疫治療 / IL-18 / 細胞動員 / 免疫学 / 併用薬 / 血管内細胞 / 獲得免疫 / 自然免疫 / サイトカイン / 血管内皮細胞 / 実臨床 / 抗腫瘍免疫応答 / 免疫関連有害事象 / 腫瘍ネオ抗原 / I型免疫応答 / バイオマーカー / NK細胞 / ターゲット探索 / 抗がん活性 / 光学分割 / ドラッグリポジショニング / 膀胱癌 / アフィニティ樹脂 / 塩酸塩 / 溶解性 / 悪性中皮腫 / in vio評価 / 薬物動態 / 膀胱がん / 代謝物 / 探索合成 / 中皮腫 / ナフトピジル / 細胞接着分子 / 微小環境 / 免疫 / 炎症 / AT2受容体 / アンギオテンシンII / キマーゼ / アルドステロン / 急性腎障害 / シスプラチン / 炎症・免疫 / シグナル伝達 / 制御性細胞 Less

実臨床に基づく併用薬の抗腫瘍免疫応答の修飾機序の解明と癌免疫治療の最適化への応用
- Principal Investigator
  
  田中稔之
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Hyogo Medical University
自然リンパ球の活性化が誘導する正常組織保護作用と抗腫瘍免疫の強化Principal Investigator
- Principal Investigator
  
  大野喜也
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Hyogo Medical University
IL-18-induced type I immune response and regulation of immune checkpoints by tumor neoantigens
- Principal Investigator
  
  Tanaka Toshiyuki
- Project Period (FY)
  2021 – 2023
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Hyogo Medical University
  Hyogo University of Health Sciences
Overcoming immune-related adverse events (irAE) induced by immune checkpoint inhibitorsPrincipal Investigator
- Principal Investigator
  
  Ohno Yoshiya
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Hyogo University of Health Sciences
Regulation of immune-checkpoint by IL-18 and its application to cancer immunotherapy
- Principal Investigator
  
  TANAKA Toshiyuki
- Project Period (FY)
  2018 – 2020
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 50020:Tumor diagnostics and therapeutics-related
- Research Institution
  Hyogo University of Health Sciences
Discovery of a novel naftopidil-based therapeutic agent for malignant mesothelioma and mechanism of action
- Principal Investigator
  
  Tadashi Shimizu
- Project Period (FY)
  2016 – 2022
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Tumor therapeutics
- Research Institution
  Hyogo Medical University
  Hyogo University of Health Sciences
Tissue-specific trafficking of immune-competent cells mediated by lymph node-associated cell trafficking signals and regulation of immune-responses towards self components.
- Principal Investigator
  
  TANAKA Toshiyuki
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Immunology
- Research Institution
  Hyogo University of Health Sciences
Elucidation of the mechanism in cisplatin-induced renal failure anddevelopment of drug therapy aimed at the mitigation of the renal toxicity of cisplatin.
- Principal Investigator
  
  UEDA Haruyasu
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  General pharmacology
- Research Institution
  Hyogo University of Health Sciences
Trafficking of immune-competent cells mediated by high endothelial venule-associated cell trafficking signals and regulation of innate and acquired immune responses.
- Principal Investigator
  
  TANAKA Toshiyuki
- Project Period (FY)
  2010 – 2012
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Immunology
- Research Institution
  Hyogo University of Health Sciences
The role of Hyaluronan-triggering epithelial to mesenchymal transition on multidrug resistance in malignant mesohtlioma cells.Principal Investigator
- Principal Investigator
  
  OHNO Yoshiya
- Project Period (FY)
  2010 – 2011
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Tumor biology
- Research Institution
  Hyogo University of Health Sciences
リンパ節特異的な細胞動員シグナルによる制御性細胞の組織特異的動員と自己応答性制御
- Principal Investigator
  
  TANAKA Toshiyuki
- Project Period (FY)
  2008 – 2009
- Research Category
  
  Grant-in-Aid for Scientific Research on Priority Areas
- Review Section
  
  Biological Sciences
- Research Institution
  Hyogo University of Health Sciences

All 2023 2021 2020 2019 2018 2015 2012 2011 2009 Other

All Journal Article Presentation

[Journal Article] Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target.2021
- Author(s)
  Hayashi N, Yamasaki A, Ueda S, Okazaki S, Ohno Y, Tanaka T, Endo Y, Tomioka Y, Masuko K, Masuko T, Sugiura R.
- Journal Title
  
  Oncotarget
  
  Volume: 12 Issue: 13 Pages: 1256-1270
- DOI
  10.18632/oncotarget.27981
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07741, KAKENHI-PROJECT-20K16315, KAKENHI-PROJECT-19H03376, KAKENHI-PROJECT-21K07229, KAKENHI-PLANNED-18H05463
[Journal Article] Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage2020
- Author(s)
  Manabe E, Ito S, Ohno Y, Tanaka T, Naito Y, Sasaki N, Asakura M, Masuyama T, Ishihara M, Tsujino T.
- Journal Title
  
  Scientific Reports
  
  Volume: 10 Issue: 1 Pages: 22023-22023
- DOI
  10.1038/s41598-020-79146-9
- Peer Reviewed / Open Access / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-18K08055, KAKENHI-PROJECT-18K07305
[Journal Article] Neutrophil/lymphocyte ratio elevation in renal dysfunction is caused by distortion of leukocyte hematopoiesis in bone marrow.2019
- Author(s)
  Ito S, Ohno Y, Tanaka T, Kobuchi S, Ayajiki K, Manabe E, Masuyama T, Jun-Ichi S, Tsujino T.
- Journal Title
  
  Renal Failure
  
  Volume: 41 Issue: 1 Pages: 284-293
- DOI
  10.1080/0886022x.2019.1597736
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K08055, KAKENHI-PROJECT-18K07305
[Journal Article] Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.2018
- Author(s)
  Ohno Y, Shingyoku S, Miyake S, Tanaka A, Fudesaka S, Shimizu Y, Yoshifuji A, Yamawaki Y, Yoshida S, Tanaka S, Sakura K, Tanaka T.
- Journal Title
  
  Oncogene
  
  Volume: 37 Issue: 49 Pages: 6357-6367
- DOI
  10.1038/s41388-018-0405-y
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-18K07305
[Journal Article] Anti-tumor effect against human cancer xenografts by a fully human monoclonal antibody to a variant 8-epitope of CD44R1 expressed on cancer stem cells2012
- Author(s)
  Masuko. K, Okazaki S., Satoh M., Tanaka G., Ikeda T., Torii R., Ueda E., Nakano T., Danbayashi M., Tsuruoka T., Ohno Y., Yagi H., Yabe N., Yoshida H., Tahara T., Kataoka S., Oshino T., Shindo T., Niwa S., Ishimoto T., Baba H., Hashimoto Y., Saya H. & Masu
- Journal Title
  
  PLoS One
  
  Volume: 7
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700889
[Journal Article] NIH3T3 cells overexpressing CD98 heavy chain resist early G1 arrest andapoptosis induced by serum starvation.2012
- Author(s)
  Hara K, Ueda S, Ohno Y, Tanaka T, Yagi H, Okazaki S, Kawahara R, Masayuki T, Enomoto T, Hashimoto Y, Masuko K, Masuko T.
- Journal Title
  
  Cancer Sci
  
  Volume: 103 Issue: 8 Pages: 1460-1466
- DOI
  10.1111/j.1349-7006.2012.02304.x
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22590440, KAKENHI-PROJECT-22700889, KAKENHI-PROJECT-23370065
[Journal Article] Oncogenicity of L-type amino-acid transporter 1(LAT1) revealed by targeted gene disruption in chicken DT40 cells : LAT1 is a promising molecular target for human cancer therapy2011
- Author(s)
  Ohkawa M., Ohno, Y., Masuko K., Takeuchi A., Suda K., Kubo A., Kawahara R., Okazaki S., Tanaka T., Saya H., Seki M., Enomoto T., Yagi H., Hashimoto Y. & Masuko T.
- Journal Title
  
  Biochem. Biophys. Res. Commun
  
  Volume: 406 Pages: 649-655
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700889
[Journal Article] Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein2011
- Author(s)
  Masuko Takashi, Ohno Yoshiya, Masuko Kazue, Yagi Hideki, Uejima Shinnya, Takechi Masayuki, Hashimoto Yoshiyuki.
- Journal Title
  
  Cancer Science
  
  Volume: 102 Pages: 25-35
- NAID
  10029288124
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700889
[Journal Article] Towards therapeutic antibodies to membrane oncoproteins by a robust strategy using rats immunized with transfectants expressing target molecules fused to green fluorescent protein2011
- Author(s)
  Masuko T, Ohno Y, Masuko K, Yagi H, Uejima S, Takechi M, Hashimoto Y.
- Journal Title
  
  Cancer Sci
  
  Volume: 102 Pages: 25-35
- NAID
  10029288124
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700889
[Journal Article] Oncogenicity of L-type amino-acid transporter 1 (LAT1) revealed by targeted gene disruption in chicken DT40 cells : LAT1 is a promising molecular target for human cancer therapy2011
- Author(s)
  Ohkawa, M., Ohno, Y., Masuko, K., Takeuchi, A., Suda, K., Kubo, A., Kawahara, R., Okazaki, S., Tanaka, T., Saya, H., Seki, M., Enomoto, T., Yagi, H., Hashimoto, Y., Masuko, T.
- Journal Title
  
  Biochem.Biophys.Res.Commun.
  
  Volume: 406 Issue: 4 Pages: 649-655
- DOI
  10.1016/j.bbrc.2011.02.135
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-21370075, KAKENHI-PROJECT-22590440, KAKENHI-PROJECT-22700889
[Journal Article] NIH3T3 cells over-expressing CD98 heavy chain resist early G1 arrest and apoptosis induced by serum starvation
- Author(s)
  Hara K., Ueda S., Ohno Y., Tanaka T., Yagi H., Okazaki S., Kawahara R., Masayuki T., Enomoto T., Hashimoto Y., Masuko K. & Masuko T
- Journal Title
  
  Cancer Sci
  
  Volume: (in press)
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22700889
[Presentation] IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockade2023
- Author(s)
  Yoshiya Ohno and Toshiyuki Tanaka
- Organizer
  JSICR/MMCB 2023 Joint Symposium
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-23K06706
[Presentation] IL-18-primed NK cells recruit dendritic cells and potentiate tumor therapy mediated by PD-1 blockade.2023
- Author(s)
  Ohno Y, Tanaka T.
- Organizer
  JSICR/MMCB 2023 Joint Symposium
- Data Source
  KAKENHI-PROJECT-21K07229
[Presentation] IL-18 recruits CD103+ dendritic cells via NK cell activation and potentiates immunotherapy mediated by PD-1 blockade2021
- Author(s)
  大野喜也、田中稔之
- Organizer
  第50回日本免疫学会
- Data Source
  KAKENHI-PROJECT-19K07741
[Presentation] IL-18 recruits CD103+ dendritic cells via NK cell activation and potentiates immunotherapy mediated by PD-1 blockade2021
- Author(s)
  Yoshiya Ohno & Toshiyuki Tanaka
- Organizer
  The 50th Annual Meeting of the Japanese Society for Immunology
- Data Source
  KAKENHI-PROJECT-21K07229
[Presentation] IL-18と免疫チェックポイント阻害薬によって誘導される抗腫瘍免疫における免疫細胞のダイナミクス2018
- Author(s)
  大野喜也、西村嘉泰、河野真己、加戸祥揮、有本奈緒子、岡村春樹、田中稔之
- Organizer
  第27回日本がん転移学会学術集会・総会
- Data Source
  KAKENHI-PROJECT-18K07305
[Presentation] IL-18と抗PD-1抗体が誘導する抗腫瘍免疫における免疫細胞動態2018
- Author(s)
  大野喜也、西村嘉泰、河野真己、加戸祥揮、有本奈緒子、岡村春樹、田中稔之
- Organizer
  第22回日本がん免疫学会総会
- Data Source
  KAKENHI-PROJECT-18K07305
[Presentation] Activin-AシグナルとCD44シグナルによる悪性中皮腫癌幹細胞の制御機構2018
- Author(s)
  大野喜也、新玉紗理奈、三宅咲奈、田中亜弥、筆坂世奈、清水雄太、吉藤愛、山脇優輝、佐倉千萬、田中稔之
- Organizer
  第68回日本薬学会近畿支部総会・大会
- Data Source
  KAKENHI-PROJECT-18K07305
[Presentation] Anti-tumor immune cell dynamics during immunotherapy with anti-PD-1 antibody and IL-18.2018
- Author(s)
  Ohno Y, Okamura H, Tanaka T.
- Organizer
  第77回日本癌学会学術総会
- Data Source
  KAKENHI-PROJECT-18K07305
[Presentation] 低酸素環境が造腫瘍性を示すCD133陽性悪性中皮腫細胞の維持に寄与する.2015
- Author(s)
  大野喜也、田中稔之
- Organizer
  第74回日本癌学会学術総会
- Place of Presentation
  名古屋国際会議場（愛知県名古屋市）
- Year and Date
  2015-10-08
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] THP-1 macrophage-like cells were induced to differentiate towards an M2-like phenotype by human malignant mesothelioma cells and enhanced the expression of stem cell-associated markers in the tumor cells.2015
- Author(s)
  Ohno Y, Tanaka T.
- Organizer
  International Conference of Cancer Immunotherapy and Macrophages 2015
- Place of Presentation
  Ito International Research Center（東京都文京区）
- Year and Date
  2015-07-09
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] Activin-ALK4 axisは悪性中皮腫細胞株MSTOのALDHhigh細胞を維持し、造腫瘍性を高める.2015
- Author(s)
  大野喜也、田中稔之
- Organizer
  第24回日本がん転移学会学術集会・総会
- Place of Presentation
  シティプラザ大阪（大阪府大阪市）
- Year and Date
  2015-07-23
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] Stem cell-like propertiesin CD133+ cells isolated from xenografted human malignant mesothelioma in immunodeficient mice.2012
- Author(s)
  Ohno Y, Tanaka T.
- Organizer
  The 71st Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  Royton Sapporo (Sapporo)
- Year and Date
  2012-09-19
- Data Source
  KAKENHI-PROJECT-22590440
[Presentation] The study of mesothelioma cancer stem cells using in vivo proliferation and sphere culture models.2012
- Author(s)
  Ohno Y, Ueda H, Tanaka T.
- Organizer
  The21st Annual Meeting of the Japanese CancerAssociation for Metastasis Research.
- Place of Presentation
  Oriental Hotel Hiroshima (Hiroshima)
- Year and Date
  2012-07-13
- Data Source
  KAKENHI-PROJECT-22590440
[Presentation] 悪性中皮腫によるヒアルロン酸産生とその細胞遊走・増殖制御における意義2009
- Author(s)
  大野喜也, et al.
- Organizer
  第18回日本がん転移学会
- Place of Presentation
  旭川グランドホテル(旭川市)
- Year and Date
  2009-07-23
- Data Source
  KAKENHI-PROJECT-20060028
[Presentation] 悪性中皮腫のスフェロイド形成とALDH陽性癌幹細胞様細胞におけるActivinの役割
- Author(s)
  清水雄太、大野喜也、田中稔之
- Organizer
  第63回日本薬学会近畿支部総会・大会
- Place of Presentation
  同志社女子大学（京都府京田辺市）
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] TGFシグナルによる悪性中皮腫スフェロイドの形成とALDH陽性癌幹細胞様細胞の制御
- Author(s)
  大野喜也、筆坂世奈、清水雄太、三宅咲奈、田中稔之
- Organizer
  第22回日本がん転移学会学術集会・総会
- Place of Presentation
  ホテルブエナビスタ（長野県松本市）
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] CD44-dependent signals and pro- and anti-inflammatory cytokines differentially regulate spheroid formation and maintenance of cancer stem-like cells in malignant mesothelioma cells.
- Author(s)
  大野喜也、田中稔之
- Organizer
  第22回マクロファージ分子細胞生物学国際シンポジウム（MMCB2014）
- Place of Presentation
  神戸商工会議所（兵庫県神戸市）
- Year and Date
  2014-06-02 – 2014-06-03
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] Spheroid forming malignant mesothelioma cells showed cancer stem cell-like properties and spontaneously produced proinflammatory cytokines
- Author(s)
  大野喜也、牛尾明雅、田中亜弥、筆坂世奈、新玉紗理奈、三宅咲奈、上田晴康、田中稔之
- Organizer
  第21回マクロファージ分子細胞生物学国際シンポジウム（MMCB2013）
- Place of Presentation
  都市センターホテル（東京都千代田区）
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] HA-CD44 axis was required for formation of malignant mesothelioma spheroids and maintenance of CSC-like ALDHhigh cells
- Author(s)
  大野喜也、田中稔之
- Organizer
  第72回日本癌学会学術総会
- Place of Presentation
  パシフィコ横浜（神奈川県横浜市）
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] 悪性中皮腫のスフェロイド形成と癌幹細胞様細胞におけるActivinの役割
- Author(s)
  清水雄太、大野喜也、田中稔之
- Organizer
  日本薬学会第134年会
- Place of Presentation
  熊本市総合体育館（熊本県熊本市）
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] CD44依存的なスフェロイド形成はactivin産生を介してALDH発現を亢進させる.
- Author(s)
  大野喜也、田中稔之
- Organizer
  第23回日本がん転移学会学術集会・総会
- Place of Presentation
  金沢市文化ホール（石川県金沢市）
- Year and Date
  2014-07-10 – 2014-07-11
- Data Source
  KAKENHI-PROJECT-25460603
[Presentation] Stem cell-like properties in CD133+ cells isolated from xenografted human malignant mesothelioma in immunodeficient mice.
- Author(s)
  Ohno Y.
- Organizer
  The 71st Annual Meeting of the Japanese Cancer Association
- Place of Presentation
  Royton Sapporo（ Sapporo ）
- Data Source
  KAKENHI-PROJECT-22590440
[Presentation] The study of mesothelioma cancer stem cells using in vivo proliferation and sphere culture models.
- Author(s)
  Ohno Y.
- Organizer
  The 21st Annual Meeting of the Japanese Cancer Association for Metastasis Research
- Place of Presentation
  オリエンタルホテル広島（広島市）
- Data Source
  KAKENHI-PROJECT-22590440

1. TANAKA Toshiyuki (30217054)

# of Collaborated Projects: 9 results

# of Collaborated Products: 23 results
2. UEDA Haruyasu (10330458)

# of Collaborated Projects: 4 results

# of Collaborated Products: 3 results
3. Tadashi Shimizu (40509022)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
4. 長屋寿雄 (60464343)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
5. 岡村春樹 (60111043)

# of Collaborated Projects: 1 results

# of Collaborated Products: 3 results
6. NAITO Yoshiro

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
7. 伊藤都裕

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
8. 辻野健

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
9. 増山理

# of Collaborated Projects: 0 results

# of Collaborated Products: 2 results
10. 関政幸

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

OHNO YOSHIYA 大野 喜也

Ohno Yoshiya 大野 喜也

OONO Yoshiya 大野 喜也

Research Projects

Research Products

Co-Researchers

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

自然リンパ球の活性化が誘導する正常組織保護作用と抗腫瘍免疫の強化Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Overcoming immune-related adverse events (irAE) induced by immune checkpoint inhibitorsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of Hyaluronan-triggering epithelial to mesenchymal transition on multidrug resistance in malignant mesohtlioma cells.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

[Journal Article] Oncogenic transformation of NIH/3T3 cells by the overexpression of L-type amino acid transporter 1, a promising anti-cancer target.2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Reduced lifespan of erythrocytes in Dahl/Salt sensitive rats is the cause of the renal proximal tubule damage2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Neutrophil/lymphocyte ratio elevation in renal dysfunction is caused by distortion of leukocyte hematopoiesis in bone marrow.2019

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways.2018

OHNO YOSHIYA 大野喜也

Ohno Yoshiya 大野喜也

OONO Yoshiya 大野喜也